KFF November 20, 2024
Jennifer Kates, Josh Michaud

With President-elect Donald Trump announcing his intention to nominate Robert F. Kennedy, Jr. as Secretary of Health and Human Services (HHS), and several other nominations expected soon, including for the heads of the Food and Drug Administration (FDA) and Centers for Disease Control and Prevention (CDC), questions have been raised about what influence these appointed health officials have over U.S. vaccine policy. Kennedy, for example, has expressed doubts about the safety and effectiveness of many vaccines, falsely claimed that vaccines are linked to autism, and voiced opposition to vaccine requirements for children, among other policy positions. Does this mean he or other federal officials could change recommendations or remove vaccines from use? Could these officials impose a different set of...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: FDA, Govt Agencies, Healthcare System, HHS, Public Health / COVID
How Donald Trump Is Reshaping Global Health
InnovationRx: The Impact Of Trump’s Withdrawal From The WHO And His Other Healthcare Orders
Critical Steps To Address Climate, Health, And Equity
Updating US Public Health For Healthier Communities
5 Lessons from Modernizing a Public Health Database System

Share This Article